A carregar...
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
SIMPLE SUMMARY: Patients with pseudomyxoma peritonei that are not cured by the standard treatment (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy) have no efficacious treatment options. Drugs that inhibit formation of new vessels (anti-angiogenic drugs) could be a therapeutic op...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8201024/ https://ncbi.nlm.nih.gov/pubmed/34198773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112819 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|